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ABSTRACT
Background. Hyperglycemia is associated with a decreased tolerance to ischemia and an
increased severity of renal ischemia reperfusion (I/R) injury. It has been suggested that
erythropoietin (EPO) attenuates this effect in normoglycemic animals. This study sought
to examine the effects of EPO on treatment renal I/R injury (IRI) in transiently
hyperglycemic rats.
Material and Methods. Twenty-eight male Wister rats anesthetized with isoflurane
received glucose (2.5 g.kg1 intraperitoneally) before right nephrectomy. They were
randomly assigned to four groups: sham operation (S); IRI (ISO); IRIEPO, (600 UI
kg1 low-dose EPO [EL]); and IRIEPO 5000 UI kg1 (high-dose EPO [EH]). IRI was
induced by a 25-minute period of left renal ischemia followed by reperfusion for 24 hours.
Serum Creatinine and glucose levels were measure at baseline (M1), immediately after the
ischemic period (M2), and at 24 hours after reperfusion (M3). After sacrificing the
animals, left kidney specimens were submitted for histological analysis including flow
cytometry to estimate tubular necrosis and the percentages of apoptotic, dead or intact
cells.
Results. Scr in the ISO group was significantly higher at M3 than among the other
groups. Percentages of early apoptotic cells in ISO group were significantly higher than the
other groups. Percentages of late apoptotic cells in S and ISO groups were significantly
greater than EL and EH groups. However, no significant intergroup differences were
observed regarding the incidence of tubular necrosis.
Conclusions. Our results suggested that, although not preventing the occurrence of
tubular necrosis, EPO attenuated apoptosis and glomerular functional impairment among
transiently hyperglycemic rats undergoing an ischemia/reperfusion insult.Ischemia reperfusion (I/R) causes acute renal injury,which is a leading cause of delayed graft dysfunction
and chronic allograft nephropathy after renal transplanta-
tion.1
Hyperglycemia is associated with a decreased tolerance
to ischemia and an increased severity of the renal I/R
injury.2
Transient hyperglycemia which is commonly found even
in non-diabetic patients after renal transplantation,3,4 may
ccentuate the ischemic renal injury, apoptosis, and anti-
enic inflammatory responses which increase the risk of
raft rejection.4
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3618Erythropoietin (EPO) administered before renal I/R may
exert renoprotective effects in normoglycemic animals.5
However, the effect has not been widely studied in tran-
siently hyperglycemic animals. We hypothesized that EPO
also exerted renoprotective effects in transiently hypoglyce-
mic rats undergoing renal I/R.
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The Institutional Review Board on Animal Experimentation ap-
proved the study. Twenty-eight male Wister rats6 weighing more
than 250 g were assigned to four groups, according to a random;
electronically generated group S (n 6) underwent sham procedures;
group ISO (n  6) to single-kidney I/R, as described elsewhere;7
group EL (n  8), low-dose EPO (600 UI.kg1 intravenously)
ollowed by single-kidney; I/R; and group EH (n  8), high-dose
rythropoietin (5000 UI.kg1 intravenously) followed by I/R. EPO
(Eprex) used in this study was purchased from Janssen Cilag
Pharmaceutical Ltd. (São Paulo, Brazil).
Isoflurane was used for Induction of anesthesia followed by
tracheal intubation. Lungs were mechanically expended through a
rodent ventilator (Harvard Rodent Ventilator 683, South Natick,
MA) that was set to deliver tidal volumes of 10 mL kg1 and a
espiratory rate of 80 breaths per minute. Further adjustments
ere made to maintain normocarbia. Oxygen (100%) and isoflu-
ane (1.5%) were administered throughout the procedure. End-
idal carbon dioxide partial pressure, and inspired and expired
nesthetic gas concentrations were continously measured through-
ut the procedure (Datex Engstron, Finland). Mean arterial pres-
ure (MAP) was electronically and continuously recorded through
catheter surgically inserted into the left carotid artery (Datex
ngstron). The right internal jugular vein was cannulated for fluid
nd drug administration as well as central venous pressure mea-
urements. Rectal temperature was maintained in the 36°C to 38°C
ange.8 Glucose (2.5 g kg1) was administered intraperitoneally
fter tracheal intubation. Lactated Ringer’s solution (3 mL min1)
was administered intravenously through a Harvard pump 22 (In-
stech, Plymouth Meeting, PA).
Each subject understand a midline laparotomy followed by a
right nephrectomy. EPO was administered intravenously to rats
assigned to groups EL (600 UI kg1) and EH (5000 UI kg1),
hich corresponded to human equivalent doses of 96 UI kg1and
00 UI kg1, respectively.9 Saline was administered to rats allo-
cated to the ISO group. Animals assigned to the sham group
underwent the same procedures, except for the renal ischemia.
Surgical wounds were infiltrated with 0.25% bupivacaine at the end
of the procedure. The inhalation anesthetic was discontinued and
hosts were allowed to recover spontaneously. After tracheal extu-
bation, animals were moved to heated individual cages. Free access
to water and food was granted postoperatively. Arterial blood
samples for measurements of serum creatinine (Scr) and glucose
(Sglu) levels were drawn after carotid artery cannulation (M1),
after kidney reperfusion (M2), and 24 hours there after (M3). Rats
were then anesthetized, sacrificed, and the left kidney excised and
sectioned longitudinally into two fragments for histological analy-
ses. One fragment was fixed in Duboscq Brazil’s solution (formal-
Table 1. Intergroup Comparisons of Mean Arterial Pressure at
the Measurement Occasions
Groups
Measurement Occasions
M1 M2 M3
S 86.1  27.4 97.0  14.9 93.0  21.5
ISO 94.7  20.0 89.7  17.4 90.2  17.9
EH 103.8  9.4 100.4  15.9 92.1  13.2
EL 102.6  19.6 82.4  21.5 84.8  24.1
Abbreviations: S, sham; ISO, single-kidney ischemia-reperfusion; EH, high-
dose erythropoietin (5000 UI kg1 intravenously) followeed by I/R; EL, low-dose
erythropoietin (600 UI - 1 intravenously) followed by ISO; M1, after carotid artery
cannulation; M2, after kidney reperfusion; M3, 24 hours after reperfusions.dehyde, picric acid, acetic acid, and absolute ethyl alcohol), em-
bedded in paraffin, stained with hematoxylin- eosin, and examined
under optical microscopy by a pathologist unaware of the groups to
from which the specimen was derived. Cell damage scores were
attributed to each specimen, according to the following classifica-
tion, based on the percentage of necrotic tubular cells in the
specimen:0 (no necrosis); 1 (mild injury), less than 10%; 2 (mod-
erate), 11% to 25%; 3 (moderately severe), 26% to 50%; 4
(severe), 51% to 75%; or 5 (very severe), when more than 75% of
examined tubular cells necrotic.10 The remaining fragment was
ubjected to flow cytometry (FCM),11–14 to measure the percent-
ages of early apoptotic, late apoptotic, dead, and intact cells.
Analyses were performed on a BD FACSCalibur™ flow cytometer
(Becton, Dickinson & Co., San Jose, CA). Normally distributed
variables (MAP, Scr, analysis of vanance and Sglu) were submitted
to two-way (groups  measuring occasions interactions) repeated
measures analysis of variance (ANOVA); followed by Student-
Newman-Kuels post hoc tests. Kruskal-Wallis tests were applied
for intergroup comparisons of histologically and FCM-derived
data. The significance level was set at   0.05.
RESULTS
The MAP values did not differ among the groups at the
measurement occasions (F(6.54) 1.83; P  .1; Table 1).
Although there were no significant group  measure-
ment occasion interaction effects (F(6,48)  2.04; P  .07)
glu levels were increased in all groups at M2. At M3, the
Table 2. Intergroup Comparisons of Serum Glucose Levels at
the Measurement Occasions
Groups
Measurement Occasions
M1 M2 M3
S 212.3  48.4 302.5  80.0* 181.8  12.7
ISO 241.2  36.0 348.3  52.3* 135.5  47.6†
EH 174.9  30.5 271.9  95.2* 166.4  26.2
EL 190.8  30.3 282.0  85.4* 163.0  31.1
Abbreviations: S, sham; ISO, single-kidney-HR ischemia-reperfusion (I/R);
EH, high-dose enythropoietin (5000 UI.kg-1 inravenously) followed by I/R; EL,
low-dose erythropoietin (600 UI.kg1 intravenously) followed by single-kidney
I/R: M1, after carotid artery cannulation; M2, after kidney reperfusion; M3, 24
hours after reperfusion.
*Significant increases in glucose levels occurred in all groups at M2 (P .01).
†P  .01 compared to the other groups, at M3.
Table 3. Intergroup Comparisons of Serum Creatinine Levels
at the Measurement Occasions
Groups
Measurement Occasions
M1 M2 M3
S 0.3  0.1 0.4  0.2 0.7  0.2*
ISO 0.4  0.0 0.7  0.1 4.4  0.9,†
EH 0.3  0.0 0.6  0.1 2.7  0.8,‡
EL 0.3  0.0 0.6  0.1 2.5  0.7,‡
Abbreviations: S, sham ISO, single-kidney ischemia-reperfusion (I/R); EH,
high-dose erythropoietin (5000 UI.kg1 intravenously) followed by I/R; EL,
low-dose erythropoietin (600 UI.kg1 intravenously) followed by single-kidney
I/R; M1, after carotid artery cannulation: M2, after kidney reperfusion; M3, 24
hours after reperfusion.
*Significant increases in glucose levels occurred in all groups at M3 (P .01).
†P  .01 compared to groups S, E, and EH at M3.
‡P  .01 compared to group S at M3.
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(Table 2).
Significant group  measurement occasion interaction
ffects were observed regarding Scr levels (F(6,50)  26.46;
P  .01). No intergroup differences were found at M1 or
M2. The ISO group exhibited significantly greater values
compared with the other groups at M3. No significant
differences were observed between EH and EL groups at
M3, although, the Scr levels of these groups were signifi-
cantly higher than those of the S group (Table 3).
Cell damage scores (median [25th; 75th percentiles]) of
idneys from the S group [0 (0;0)] were significantly lower
han those of the EH (4.0 [4.0; 4.0]); EL (4.5 [4.0; 5.0]) and
SO (5.0 [3.5; 5.0]) groups (P  .001).
The percentage of early apoptotic cells in specimens from
the ISO group were significantly higher than those of the
other groups. Percentages of late apoptotic cells in speci-
mens from S and ISO groups were significantly higher than
those obtained from EH and EL groups. No significant
differences were noted regarding the percentages of dead
cells in the specimens among the groups. The percentages
of intact cells in specimens from S, EH, and EL groups were
significantly greater higher than those found in the ISO
group (Table 4).
DISCUSSION
The main finding of this study was significants attenuation
of renal tubular cells apoptosis following administration of
EPO before the induction of I/R in rats made hyperglyce-
mic by intraperitoneal administration of glucose. This ob-
servation may be a consequence of the inhibition of
caspases, especially caspase 3. Which mediates apoptosis in
hyperglycemic environment.15
This effect was accompanied by glomerular functional
loss as the Scr levels were significantly lower among rats
receiving EPO. It has been shown that EPO inhibits the
expression of inflammatory cytokines interleukin-10 and
tumor necrosis factor–,16 which may explain our findings.
This study confirmed other findings that hyperglycemia
tself is assoicated with renal injury,17 as Rats-undergoing
sham procedures exhibited significantly higher percentages
of late apoptotic tubular cells.
We also observed that cell necrosis was not affected by
erytpetin administration, suggesting that although decreas-
ing the deleterious effects on tubular cells, of I/R the EPO
Table 4. Percentages of Tubular Cells in Specimens of
Classes S
Early apoptotic 4.9 [2.5; 6.9] 48.2† 5.7 [2
Late apoptotic 1.2† [0.7; 1.9] 5.7† [2
Dead 3.9 [0.7; 10.0] 4.7 [0
Intact 85.8 [82.7; 91.4] 45.2† [3
Abbreviations; S, sham; ISO, single-kidney ischemia-reperfusion (I/R); EH, h
erythropoietin (600 UI.kg1, intravenously) followed by single-kidney I/R.
Expressed as median E [25th percentile; 75th percentile].
†P  .01 compared to the other groups.dosages of used in this study were not sufficient to preventtubular necrosis. Given the small number of animals in each
group, our study may have been underpowered to detect
the existence of small differences.
Another interesting finding was that Sgl levels at 24 hours
after reperfusion were significantly lower in among animals
that did not receive EPO, but underwent renal ischemia
(group ISO). Increased glucose and amino acid excretion
and decreased sodium reabsorption are known to be asso-
ciated with renal cell injury and decreased glomerular
function,18 among animals experiencing renal ischemia.
Because no difference in Sglu levels was shown among the
other groups, this finding may provide additional evidence
for the protective effects of EPO administered before a
renal ischemic insult.
It has been shown that the synthesis of EPO is inhibited
by transient hyperglycemia associated with kidney I/R in-
jury.19 Although we did not measure blood levels of EPO in
this study, we speculate that the exogenously administered
hormone may have compensated to some extent for the
decreased endogenous EPO levels.
Neutrophil infiltration and activation have been as-
soicated with I/R-induced tubular cell injury in transiently
hyperglycemic rats. D-ribose administered before induction
of renal ischemia attenuates this effect,20 suggesting several
mechanisms are involved in I/R-induced tubular cell dam-
age in hyperglycemic rats. Thus, the concomitant use of
multiple pharmacological interventions may produce more
pronounced protective effects, an hypothesis that deserves
further study.
We concluded that EPO attenuated apoptosis and im-
pairment of glomerular function but not tubular necrosis, in
transiently hyperglycemic rats undergoing an to I/R insult.
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